Cargando…

The efficacy of guided growth as an initial strategy for Blount disease treatment

PURPOSE: The aim of this study was to evaluate the success of guided growth by temporal hemiepiphysiodesis of the lateral proximal tibia as a first line treatment option for Blount disease. METHODS: This was a retrospective multicentre study conducted in five centres, covering data on 55 limbs in 45...

Descripción completa

Detalles Bibliográficos
Autores principales: Danino, Barry, Rödl, Robert, Herzenberg, John E., Shabtai, Lior, Grill, Franz, Narayanan, Unni, Gigi, Roy, Segev, Eitan, Wientroub, Shlomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone & Joint Surgery 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453169/
https://www.ncbi.nlm.nih.gov/pubmed/32874365
http://dx.doi.org/10.1302/1863-2548.14.200070
_version_ 1783575304510373888
author Danino, Barry
Rödl, Robert
Herzenberg, John E.
Shabtai, Lior
Grill, Franz
Narayanan, Unni
Gigi, Roy
Segev, Eitan
Wientroub, Shlomo
author_facet Danino, Barry
Rödl, Robert
Herzenberg, John E.
Shabtai, Lior
Grill, Franz
Narayanan, Unni
Gigi, Roy
Segev, Eitan
Wientroub, Shlomo
author_sort Danino, Barry
collection PubMed
description PURPOSE: The aim of this study was to evaluate the success of guided growth by temporal hemiepiphysiodesis of the lateral proximal tibia as a first line treatment option for Blount disease. METHODS: This was a retrospective multicentre study conducted in five centres, covering data on 55 limbs in 45 patients, with an average follow-up of 24.5 months following plate insertion. Preoperative alignment analysis was compared with three measurements taken postoperatively. The normalization of the mechanical medial proximal tibia angle (mMPTA) was defined as the primary outcome measure. RESULTS: Mean age at surgery was 9.5 years. Average preoperative mMPTA was 77°. On average, at 24.5 months post-surgery, mMPTA was 86.33°, while 43/55 limbs (78.18%) have achieved normalization (mMPTA 85° to 90°). Average rate of correction was 1° per month. When grouping the children as infantile (11 limbs), juvenile (12 limbs) and adolescent (32 limbs), operated on before the age of four years, between four and ten years and after the age of ten years, respectively, 63.63%, 66.67%, 87.5% have completed correction of deformity during the follow-up period. Interestingly, the femoral component of the deformity has achieved correction as well in 33/55 limbs (64%). CONCLUSION: Hemiepiphysiodesis is an effective first line treatment for Blount disease. Overall success rate is good but varies according to child’s age. Adolescent Blount has the best chance of achieving full correction while same treatment is less effective in infantile Blount. Level of evidence: IV
format Online
Article
Text
id pubmed-7453169
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The British Editorial Society of Bone & Joint Surgery
record_format MEDLINE/PubMed
spelling pubmed-74531692020-08-31 The efficacy of guided growth as an initial strategy for Blount disease treatment Danino, Barry Rödl, Robert Herzenberg, John E. Shabtai, Lior Grill, Franz Narayanan, Unni Gigi, Roy Segev, Eitan Wientroub, Shlomo J Child Orthop Original Clinical Article PURPOSE: The aim of this study was to evaluate the success of guided growth by temporal hemiepiphysiodesis of the lateral proximal tibia as a first line treatment option for Blount disease. METHODS: This was a retrospective multicentre study conducted in five centres, covering data on 55 limbs in 45 patients, with an average follow-up of 24.5 months following plate insertion. Preoperative alignment analysis was compared with three measurements taken postoperatively. The normalization of the mechanical medial proximal tibia angle (mMPTA) was defined as the primary outcome measure. RESULTS: Mean age at surgery was 9.5 years. Average preoperative mMPTA was 77°. On average, at 24.5 months post-surgery, mMPTA was 86.33°, while 43/55 limbs (78.18%) have achieved normalization (mMPTA 85° to 90°). Average rate of correction was 1° per month. When grouping the children as infantile (11 limbs), juvenile (12 limbs) and adolescent (32 limbs), operated on before the age of four years, between four and ten years and after the age of ten years, respectively, 63.63%, 66.67%, 87.5% have completed correction of deformity during the follow-up period. Interestingly, the femoral component of the deformity has achieved correction as well in 33/55 limbs (64%). CONCLUSION: Hemiepiphysiodesis is an effective first line treatment for Blount disease. Overall success rate is good but varies according to child’s age. Adolescent Blount has the best chance of achieving full correction while same treatment is less effective in infantile Blount. Level of evidence: IV The British Editorial Society of Bone & Joint Surgery 2020-08-01 /pmc/articles/PMC7453169/ /pubmed/32874365 http://dx.doi.org/10.1302/1863-2548.14.200070 Text en Copyright © 2020, The author(s) http://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed.
spellingShingle Original Clinical Article
Danino, Barry
Rödl, Robert
Herzenberg, John E.
Shabtai, Lior
Grill, Franz
Narayanan, Unni
Gigi, Roy
Segev, Eitan
Wientroub, Shlomo
The efficacy of guided growth as an initial strategy for Blount disease treatment
title The efficacy of guided growth as an initial strategy for Blount disease treatment
title_full The efficacy of guided growth as an initial strategy for Blount disease treatment
title_fullStr The efficacy of guided growth as an initial strategy for Blount disease treatment
title_full_unstemmed The efficacy of guided growth as an initial strategy for Blount disease treatment
title_short The efficacy of guided growth as an initial strategy for Blount disease treatment
title_sort efficacy of guided growth as an initial strategy for blount disease treatment
topic Original Clinical Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453169/
https://www.ncbi.nlm.nih.gov/pubmed/32874365
http://dx.doi.org/10.1302/1863-2548.14.200070
work_keys_str_mv AT daninobarry theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT rodlrobert theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT herzenbergjohne theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT shabtailior theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT grillfranz theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT narayananunni theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT gigiroy theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT segeveitan theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT wientroubshlomo theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT daninobarry efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT rodlrobert efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT herzenbergjohne efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT shabtailior efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT grillfranz efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT narayananunni efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT gigiroy efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT segeveitan efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment
AT wientroubshlomo efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment